Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice. - Wikidata - wikimedia - TriplyDB

Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.

Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.

http://www.wikidata.org/entity/Q37676966

about

NRF2, a Key Regulator of Antioxidants with Two Faces towards Cancer Linking uric acid metabolism to diabetic complications Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis Hypaphorine Attenuates Lipopolysaccharide-Induced Endothelial Inflammation via Regulation of TLR4 and PPAR-γ Dependent on PI3K/Akt/mTOR Signal Pathway.Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort.Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice Focal induction of ROS-release to trigger local vascular degeneration Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.The Effects of Xanthine Oxidoreductase Inhibitors on Oxidative Stress Markers following Global Brain Ischemia Reperfusion Injury in C57BL/6 Mice.Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice.Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation.Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study.Hydroxysafflor Yellow A Inhibits LPS-Induced NLRP3 Inflammasome Activation via Binding to Xanthine Oxidase in Mouse RAW264.7 Macrophages Alcohol Abuse is Associated with Enhanced Pulmonary and Systemic Xanthine Oxidoreductase Activity.Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice.Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation.Eating the Dead to Keep Atherosclerosis at Bay.Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.XOR inhibition with febuxostat accelerates pulmonary endothelial barrier recovery and improves survival in lipopolysaccharide-induced murine sepsis.Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner.Honey as an apitherapic product: its inhibitory effect on urease and xanthine oxidase.Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.Cafestol Inhibits Cyclic-Strain-Induced Interleukin-8, Intercellular Adhesion Molecule-1, and Monocyte Chemoattractant Protein-1 Production in Vascular Endothelial Cells.Nanoparticles in Medicine: A Focus on Vascular Oxidative Stress

P2860

Q26747249-766D06D4-8592-4C3E-8CD3-9763CC1E51D9 Q26996416-96830A42-FAB8-416E-9C55-8C814DB7269D Q28354735-34F1F37D-21B0-4D34-98BD-5A6EA65B8F81 Q33624829-530E7298-9CAB-4815-A67B-503B07C268E9 Q33632726-1705A2DA-AEF7-454A-B111-A633A4366FAF Q33683082-BF221032-03A9-4A64-A90C-10818A094542 Q33797478-A01C892E-FA6F-4EA5-ABEB-CF3870D9F15C Q33885504-EB83DD02-586B-4CBC-8EA2-B1F3C0B9169B Q35730004-D8628BF7-C8D4-487F-9191-4E7F0CA303DA Q36354759-BD2D03C3-AB80-41F5-B41D-0E72B487CFEE Q37012131-81A163F8-337A-4A8E-B167-2AE3F82FBB3F Q37018125-F262A891-3D10-474A-8C62-4DF4A029B6CA Q37084383-6EA6FCB1-C6B4-499F-BCF4-08C20CFAA1D2 Q38609440-AC0A6DBF-D662-476E-8BB3-8B509E455A38 Q38648316-EC9F603A-884D-4D0B-BAEF-E8F00C72AEA2 Q38721496-290CAD91-7F85-4CDA-9EE6-E9F79FC44A4E Q39134393-8353B6AA-7D3E-4A79-B331-C940FE9375AD Q40417250-FDB8AB7E-98EE-4A7E-80CA-8A27B809FE68 Q41386068-311691AB-B0D9-4909-8469-8E38B53F90B6 Q41526360-15CCF9FC-AEAC-4C22-BA04-682EE1D10AF6 Q46225596-5EF0E7D7-84FF-4FA5-8299-755B7444821E Q46733539-18940D9C-0AC5-4A5C-8A98-8A8A69A6AC1A Q50850318-F727B6C4-4A2C-4D9D-83FC-BE3D50F537AF Q54977487-826CED54-F22C-410D-B5BC-639CAA68C1AF Q57821326-3B725214-6346-4DC8-B228-88FEA8B021CF

P2860

Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.

http://www.wikidata.org/entity/Q37676966

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.

@en

Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.

@nl

type

label

Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.

@en

Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.

@nl

prefLabel

Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.

@en

Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.

@nl

P1433

Q37676966-4374D13A-63EA-4232-A966-AEC8B7703C98

P1476

Q37676966-9C40D21B-3E1A-4A91-A180-05D747742CD1

P2093

Q37676966-133FCAC5-A32E-4144-BE37-ABABBCD99AEB

Q37676966-28FD5B1A-84FA-4BA0-A979-42ACD91F9A86

Q37676966-3835D54E-F339-44B6-BBFD-2DB78C22BB70

Q37676966-46131653-39DD-4FFE-813C-916B55AF586B

Q37676966-78171900-0A48-46A0-B69B-0C66CBFF601B

Q37676966-7BD2F153-C145-4E2E-805D-9293B66A7ADF

Q37676966-977DE0C9-7E06-4D02-ADF5-73CD6B0A0E9A

Q37676966-9E82F488-9C7F-4F7B-9E5E-580247D93656

Q37676966-D003C265-A6F8-4309-8D15-A7F5021D6814

Q37676966-DD4F5046-0EEE-44EE-9A11-9001F39DCC7C

P2860

Q37676966-08A5B2AA-7995-4C9A-BB96-9F01A8CD5758

Q37676966-0D0E2C0B-22EB-4D9C-B4D0-40EE50A3F17D

Q37676966-1539D8AB-07F2-49BA-A569-29F9A358AD13

Q37676966-20168EA4-255C-441B-BA0C-3E6BD13579BA

Q37676966-219F435E-B417-4E1B-A3C3-B5CC96C35EA8

Q37676966-2E463856-7624-4348-93D3-9193C7A4FA66

Q37676966-3407AF15-3E5B-4653-A5D8-8C7665EAA0FE

Q37676966-3BBDDB42-F24E-4BD1-958A-2E475E98B934

Q37676966-3F385887-0A04-4BC5-8853-518C0C4356F4

Q37676966-461A73B6-A88D-4D08-9B01-D7AB6BA7BD01

P2888

Q37676966-442EB3A2-C371-41B0-8A6A-01285D6CBFB7

P304

Q37676966-24C93C9E-F9E7-43E9-91FA-4447B2CDE23C

P31

Q37676966-D1DA82D8-0A46-4A1D-A3D7-ADAA9A171D56

P356

Q37676966-70FE4ECA-8D78-4DE4-8509-AD202C0655FA

P407

Q37676966-5C6E3118-6D43-474C-9458-2FCCA597CA8B

P478

Q37676966-C6C2743A-6AB3-4E93-93C9-A1A0C0F21715

P577

Q37676966-92849B13-25DC-4ED1-9149-76C90E198956

P5875

Q37676966-56442AF9-5C17-4172-B02A-A932BBFE00D4

P6179

Q37676966-B3A21E38-7883-462A-AEC5-FF22DA23234E

P698

Q37676966-8CF0F737-8D4B-40CE-9972-A937216858AB

P921

Q37676966-01DF2068-763F-4C44-BBD3-24D885E6CC6E

P932

Q37676966-AA303E7B-E859-463D-BFC5-16D1C4373B20

P356

P1433

Scientific Reports

P1476

Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.

@en

P2093

Alexander So

http://www.w3.org/2001/XMLSchema#string

Annette Ives

http://www.w3.org/2001/XMLSchema#string

Chieko Matsui

http://www.w3.org/2001/XMLSchema#string

Johji Nomura

http://www.w3.org/2001/XMLSchema#string

Mizuho Tamura

http://www.w3.org/2001/XMLSchema#string

Nathalie Busso

http://www.w3.org/2001/XMLSchema#string

Syunsuke Tsujimoto

http://www.w3.org/2001/XMLSchema#string

Takashi Shirakura

http://www.w3.org/2001/XMLSchema#string

Tsunefumi Kobayashi

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Yamanaka

http://www.w3.org/2001/XMLSchema#string

P2860

Nitric oxide synthases: regulation and function

CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.

The immune system in atherosclerosis.

Oxidized low density lipoprotein induced caspase-1 mediated pyroptotic cell death in macrophages: implication in lesion instability?

Febuxostat, an inhibitor of xanthine oxidase, suppresses lipopolysaccharide-induced MCP-1 production via MAPK phosphatase-1-mediated inactivation of JNK

Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome.

Efficacy and safety of febuxostat in patients with hyperuricemia and gout.

P2888

P304

4554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP04554

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261255993

http://www.w3.org/2001/XMLSchema#string

P6179

1043428246

http://www.w3.org/2001/XMLSchema#string

P698

24686534

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3971401

http://www.w3.org/2001/XMLSchema#string